Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Description

The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.

Conditions

Cancer of Pancreas

Study Overview

Study Details

Study overview

The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.

Cell-free Chromatin Immunoprecipitation (CfChIP) from Blood Plasma As a Diagnostic and Prognostic Tool in Pancreatic Ductal Adenocarcinoma

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Condition
Cancer of Pancreas
Intervention / Treatment

-

Contacts and Locations

Orlando

University of Central Florida, Orlando, Florida, United States, 32816

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years old or older
  • * Pancreatic cancer patients
  • * Children may not register
  • * Persons who are unable to consent may not register

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Central Florida,

Kersten Schroeder, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

2025-05